MEDP · Transaction May 15, 2026 · Filed May 28, 2026 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · MEDP
-0.47% · -$2.74 · Vol 148.7K
Market closed · last close 4:00 PM ET · price as of 16:00:25 ET
Medpace Holdings Inc
Life Sciences Tools & Services
$585.01
Veridion Score
BETAMEDIUM CONF · 5/6 factorsThu Aug 6 · market closed · Markets closed · resumes Fri 9:30 ET · MEDP
MethodologyMEDP
Medpace Holdings Inc
Thu Aug 6 · market closed · Markets closed · resumes Fri 9:30 ET
NEUTRAL
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
45/ 100
Veridion Score
NEUTRAL · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Thu Aug 6 · market closed · Markets closed · resumes Fri 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is MEDP moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Medpace Holdings Inc
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHListed since
2016
Employees
7K
Country
US
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$588.00
Day high
$590.00
Day low
$576.72
Previous close
$587.75
52W high
$620.59
-5.73% from high
52W low
$393.42
84% of range
Market cap
$16.4B
P/E
37.77×
EPS
$15.49
Beta
0.31
Shares out
27.9M
Volume
148.7K
0.41× rel vol
Avg volume
366.6K
VWAP
$583.58
Price history computed in-house
1W
+1.37%
1M
+9.97%
3M
+37.97%
1Y
+36.43%
YTD
+4.16%
SMA 50 $516.46 · above
SMA 200 $519.24 · above
52W position 84%
MEDP overview
Veridion Score
45
5 of 6 factors measured
Congress receipts
5
David J. Taylor · Purchase
13F holders
None on file
Related filings and maps
Public disclosures
Congress activity in MEDP
Official filing ↗
MEDP · Transaction Feb 26, 2026 · Filed Mar 6, 2026 · $1,001 to $15,000
MEDP · Transaction Jan 29, 2026 · Filed Feb 2, 2026 · $1,001 to $15,000
David J. TaylorSell
MEDP · Transaction Jan 16, 2026 · Filed Feb 2, 2026 · $1,001 to $15,000
MEDP · Transaction Jan 15, 2026 · Filed Feb 13, 2026 · $15,001 to $50,000
Federal contracts
MEDP contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for MEDP in this window.
Lobbying spend
MEDP lobbying filings, year to date.
Registered lobbying filings matched to Medpace Holdings Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for MEDP in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for MEDP.
Options
Sovereign unlock shows live options positioning for MEDP.